Page 152 - 南京医科大学学报自然科学版
P. 152
第42卷第1期
·146 · 南 京 医 科 大 学 学 报 2022年1月
[19] JACOT W,COTTU P,BERGER F,et al. Actionability of search project of a prospective randomized phase Ⅲ trial
HER2⁃amplified circulating tumor cells in HER2⁃nega⁃ [J]. PLoS One,2017,12(6):e0173593
tive metastatic breast cancer:the Circe T⁃DM1 trial[J]. [23] WALLWIENER M,HARTKOPF A D,RIETHDORF S,et
Breast Cancer Res,2019,21(1):121 al. The impact of HER2 phenotype of circulating tumor
[20] DEUTSCH T M,RIETHDORF S,FREMD C,et al. HER2⁃ cells in metastatic breast cancer:a retrospective study in
targeted therapy influences CTC status in metastatic 107 patients[J]. BMC Cancer,2015,15:403
breast cancer[J]. Breast Cancer Res Treat,2020,182 [24] GANCBERG D,DI LEO A,CARDOSO F,et al. Compari⁃
(1):127-136 son of HER⁃2 status between primary breast cancer and
[21] BIDARD F C,FEHM T,IGNATIADIS M,et al. Clinical corresponding distant metastatic sites[J]. Ann Oncol,
application of circulating tumor cells in breast cancer: 2002,13(7):1036-1043
overview of the current interventional trials[J]. Cancer [25] JORDAN N V,BARDIA A,WITTNER B S,et al. HER2
Metastasis Rev,2013,32(1/2):179-188 expression identifies dynamic functional states within cir⁃
[22] JAEGER B S,NEUGEBAUER J,ANDERGASSEN U,et culating breast cancer cells[J]. Nature,2016,537
al. The HER2 phenotype of circulating tumor cells in (7618):102-106
HER2 ⁃ positive early breast cancer:a translational re⁃ [收稿日期] 2020-03-02
(本文编辑:蒋 莉)
(上接第120页)
及耐药性分析[J]. 临床和实验医学杂志,2015,14(6):
level modelling analysis[J]. Lancet Infect Dis,2019,19 512-515
(1):56-66 [17] 朱英娟,王春媛,顾国忠,等. 血流感染的病原学分布和
[14] 吴 旻,陈 琼,许湘飞,等. 碳青霉烯类耐药高黏液型 危险因素及抗菌药敏感性分析[J]. 当代医学,2020,26
肺炎克雷伯菌分子流行病学和患者临床特征研究[J]. (35):175-177
实用预防医学,2020,27(12):1525-1528 [18] 马曦立,刘 霞,吴 鑫,等. 慢性肾功能衰竭血液透析
[15] DURDU B,HAKYEMEZ I N,BOLUKCU S,et al. Mortality 导管相关性血流感染病原菌耐药性及其影响因素[J].
markers in nosocomial Klebsiella pneumoniae blood⁃ 中华医院感染学杂志,2021,31(3):385-389
stream infection[J]. Springerplus,2016,5(1):1892 [收稿日期] 2021-02-04
[16] 陈 娜,苏建荣. 血培养阳性混合菌感染的病原菌分布 (本文编辑:蒋 莉)